# Evaluation of Cardiac Compass With OptiVol in the Early Detection of Decompensation Events for Heart Failure

> **NCT00510198** · NA · TERMINATED · sponsor: **Medtronic Cardiac Rhythm and Heart Failure** · enrollment: 120 (actual)

## Conditions studied

- Congestive Heart Failure

## Interventions

- **DEVICE:** Cardiac Compass with OptiVol Fluid Status Monitoring
- **DEVICE:** Standard of Care alone (clinical assessment)

## Key facts

- **NCT ID:** NCT00510198
- **Lead sponsor:** Medtronic Cardiac Rhythm and Heart Failure
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-10
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 120 (ACTUAL)
- **Why stopped:** Study enrollment significantly below protocol expectation
- **Last updated:** 2019-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00510198

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00510198, "Evaluation of Cardiac Compass With OptiVol in the Early Detection of Decompensation Events for Heart Failure". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00510198. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*